[Hyperkinetic syndromes. Therapeutic trials].

The Authors report their therapeutic experiences with RO 5/4023 begun in 1969, on some hyperkinetic syndromes. The casuistry includes six cases of facial spasm, three cases of Huntington disease, three cases of benign essential tremor, one case of Gilles de La Tourette disease. The favourable results of the drug are estimated in percentage that in somecases has reached 70%.